Growth Metrics

Assembly Biosciences (ASMB) Receivables - Net (2017 - 2025)

Assembly Biosciences (ASMB) has 9 years of Receivables - Net data on record, last reported at $912000.0 in Q3 2025.

  • For Q3 2025, Receivables - Net changed N/A year-over-year to $912000.0; the TTM value through Sep 2025 reached $912000.0, changed N/A, while the annual FY2023 figure was $43000.0, 95.44% down from the prior year.
  • Receivables - Net reached $912000.0 in Q3 2025 per ASMB's latest filing, up from $43000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.2 million in Q3 2022 and bottomed at $43000.0 in Q4 2023.
  • Average Receivables - Net over 5 years is $530692.3, with a median of $523000.0 recorded in 2022.
  • Peak YoY movement for Receivables - Net: skyrocketed 180.95% in 2022, then crashed 95.44% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $336000.0 in 2021, then soared by 180.95% to $944000.0 in 2022, then plummeted by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then skyrocketed by 2020.93% to $912000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $912000.0 in Q3 2025, $43000.0 in Q1 2024, and $43000.0 in Q4 2023.